share_log

Advent Technologies Hldgs Analyst Ratings

Benzinga Analyst Ratings ·  Oct 25, 2022 07:04
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/25/2022 750% Credit Suisse $18 → $17 Maintains Neutral
06/16/2022 100% Jefferies $11.2 → $4 Maintains Buy
03/19/2021 800% Jefferies → $18 Initiates Coverage On → Buy

Advent Technologies Hldgs Questions & Answers

What is the target price for Advent Technologies Hldgs (ADN)?

The latest price target for Advent Technologies Hldgs (NASDAQ: ADN) was reported by Credit Suisse on October 25, 2022. The analyst firm set a price target for $17.00 expecting ADN to rise to within 12 months (a possible 750.00% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Advent Technologies Hldgs (ADN)?

The latest analyst rating for Advent Technologies Hldgs (NASDAQ: ADN) was provided by Credit Suisse, and Advent Technologies Hldgs maintained their neutral rating.

When is the next analyst rating going to be posted or updated for Advent Technologies Hldgs (ADN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Advent Technologies Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Advent Technologies Hldgs was filed on October 25, 2022 so you should expect the next rating to be made available sometime around October 25, 2023.

Is the Analyst Rating Advent Technologies Hldgs (ADN) correct?

While ratings are subjective and will change, the latest Advent Technologies Hldgs (ADN) rating was a maintained with a price target of $18.00 to $17.00. The current price Advent Technologies Hldgs (ADN) is trading at is $2.00, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment